ArticleHemaSphere2024

Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myeloma.

Wassilis S C Bruins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.